These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21910285

  • 1. In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
    Kapil A, Bali R, Das BK.
    Indian J Med Res; 2001 Feb; 113():60-2. PubMed ID: 21910285
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY, Chang SC, Hsueh PR, Feng NH, Wang JT.
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [Abstract] [Full Text] [Related]

  • 3. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK, Kelkar RS.
    Indian J Cancer; 2002 Dec; 39(4):135-8. PubMed ID: 12928571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I, Voeckl J, Machka K.
    Arzneimittelforschung; 1980 Dec; 30(3):491-5. PubMed ID: 7387761
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of isepamicin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium.
    Belgian Isepamicin Multicenter Study Group.
    Acta Clin Belg; 2001 Dec; 56(5):307-15. PubMed ID: 11774843
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y, Hu Y.
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF, Alagia I, Giaquinto E, Giordano B, Leonessa V, Altucci P.
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A, Lalitha MK, Jesudason MV.
    Natl Med J India; 1997 Dec; 10(2):61-2. PubMed ID: 9153980
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A, Montini G, Ramacciotti PG.
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.